Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,676 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and efficacy of neoadjuvant chemoradiotherapy with moderately hypofractionated intensity-modulated radiotherapy for resectable pancreatic cancer: A prospective, open-label, phase II study.
Masui T, Nagai K, Anazawa T, Kasai Y, Yogo A, Yoshimura M, Mizowaki T, Uza N, Fukuda A, Matsumoto S, Kanai M, Isoda H, Kawaguchi Y, Uemoto S, Hatano E. Masui T, et al. Among authors: kawaguchi y. Cancer Med. 2023 Sep;12(18):18611-18621. doi: 10.1002/cam4.6470. Epub 2023 Aug 30. Cancer Med. 2023. PMID: 37649318 Free PMC article.
Impact of neoadjuvant intensity-modulated radiation therapy on borderline resectable pancreatic cancer with arterial abutment; a prospective, open-label, phase II study in a single institution.
Masui T, Nagai K, Anazawa T, Sato A, Uchida Y, Nakano K, Yogo A, Kaneda A, Nakamura N, Yoshimura M, Mizowaki T, Uza N, Fukuda A, Matsumoto S, Kanai M, Isoda H, Mizumoto M, Seo S, Hata K, Taura K, Kawaguchi Y, Takaori K, Uemoto S, Hatano E. Masui T, et al. Among authors: kawaguchi y. BMC Cancer. 2022 Jan 29;22(1):119. doi: 10.1186/s12885-022-09244-6. BMC Cancer. 2022. PMID: 35093003 Free PMC article. Clinical Trial.
Radiotherapy for patients with isolated local recurrence of primary resected pancreatic cancer. Prolonged disease-free interval associated with favorable prognosis.
Nakamura A, Itasaka S, Takaori K, Kawaguchi Y, Shibuya K, Yoshimura M, Matsuo Y, Mizowaki T, Uemoto S, Hiraoka M. Nakamura A, et al. Among authors: kawaguchi y. Strahlenther Onkol. 2014 May;190(5):485-90. doi: 10.1007/s00066-014-0610-8. Epub 2014 Mar 6. Strahlenther Onkol. 2014. PMID: 24599344
A Prospective Study of Intensity-modified Radiation Therapy in Comparison with Conventional 3D-RT for BR Pancreatic Cancer Patients with Arterial Involvement.
Masui T, Takaori K, Anazawa T, Sato A, Nakano K, Uchida Y, Yogo A, Goto Y, Matsumoto S, Kodama Y, Kanai M, Isoda H, Mizumoto M, Kawaguchi Y, Shibuya K, Itasaka S, Uemoto S. Masui T, et al. Among authors: kawaguchi y. Anticancer Res. 2017 Dec;37(12):7023-7030. doi: 10.21873/anticanres.12172. Anticancer Res. 2017. PMID: 29187490
Risk factors for short recurrence-free survival after resection of pancreatic neuroendocrine tumor (PanNET) liver metastases: which patients should undergo resection?
Masui T, Nagai K, Anazawa T, Kasai Y, Sato A, Nakano K, Uchida Y, Yogo A, Kawaguchi Y, Takaori K, Uemoto S. Masui T, et al. Among authors: kawaguchi y. Scand J Gastroenterol. 2020 Apr;55(4):479-484. doi: 10.1080/00365521.2020.1743352. Epub 2020 Mar 30. Scand J Gastroenterol. 2020. PMID: 32223573
Prognostic value of metastin expression in human pancreatic cancer.
Nagai K, Doi R, Katagiri F, Ito T, Kida A, Koizumi M, Masui T, Kawaguchi Y, Tomita K, Oishi S, Fujii N, Uemoto S. Nagai K, et al. Among authors: kawaguchi y. J Exp Clin Cancer Res. 2009 Jan 21;28(1):9. doi: 10.1186/1756-9966-28-9. J Exp Clin Cancer Res. 2009. PMID: 19154616 Free PMC article.
2,676 results